Boston Scientific's Synergy
Boston Scientific's Synergy stent is made with thinner struts and a bioabsorbable polymer coating that dissolves about three months after implantation, with the intention of quicker healing.
Synergy gained CE Mark in October 2012 and has become a popular choice for with European physicians. On a recent earnings call, Boston Scientific executives noted that Synergy makes up 30% of company's drug-eluting stent sales in Europe.
Synergy was the subject of the EVOLVE II U.S. pivotal trial. U.S. patients won't have to wait long . . . the stent is expected to gain FDA approval by the end of 2015.
Continue on to "Are These Medical Devices Safe?"
[Image courtesy of BOSTON SCIENTIFIC CORP]